Office Of The U.S. Trade Representative Requests Comments On Expanding WTO Duty-Free Pharmaceutical List

The Trade Policy Staff Committee of the Office of the U.S. Trade Representative has published notice in the Federal Register on March 12, 2010, regarding the possible additions of pharmaceutical products and chemical intermediates to the existing duty-free pharmaceutical list. The current list is identified in the Pharmaceutical Appendix to the Harmonized Tariff Schedule of the United States. The list is the outcome of World Trade Organization (WTO) negotiations that resulted in the "zeroing" of duties arrived at pursuant to WTO negotiations.

A new round of WTO negotiations will begin in April 2010. The Trade Policy Staff Committee has requested comments by April 9, 2010.

If you would like further information about this Alert or are interested in participating in the announced review, please contact Brian S. Goldstein, any member of the International Practice Group, any member of the Pharmaceutical & Biotechnology Industry Group or the attorney in the firm with whom you are regularly in contact.

This article is for general information and does not include full legal analysis of the matters presented. It should not be construed or relied upon as legal advice or legal opinion on any specific facts or circumstances. The description of the results of any specific case or...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT